Pain Relief Tablet Franchise in Ahmedabad

Pharma Tablet Supplier in Mumbai

Pain Management Medicine Distributor in Delhi

Tapentadol Tablet Manufacturer in Bangalore

Pharma Tablet Stockist in Hyderabad
Pain Relief Tablet Exporter in Chandigarh

Home/Products /tapentadol-50mg-tablet

About the Product

Tapentadol 50 mg Tablet is a centrally acting analgesic used for the treatment of moderate to severe pain. It is commonly prescribed for conditions such as musculoskeletal pain, postoperative pain, and chronic pain disorders.

Common side effects may include nausea, vomiting, dizziness, drowsiness, constipation, and headache. Some patients may experience dry mouth or sweating. Serious side effects can include respiratory depression, low blood pressure, or risk of dependence with prolonged use.

Tapentadol (50 mg) Tablet is indicated for the management of moderate to severe acute pain. It acts as a centrally acting opioid analgesic, helping to relieve pain by altering the way the brain perceives and responds to pain signals.

This medicine should be used under strict medical supervision due to the risk of addiction, abuse, and respiratory depression. Avoid alcohol and other CNS depressants while taking this medication. Do not exceed the prescribed dose. Use with caution in patients with respiratory disorders, liver or kidney impairment.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep in the original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation